enVVeno Medical (NVNO) October 2021 Investor Presentation

enVVeno Medical presents its lead product VenoValve, a medical device in development for treating chronic venous insufficiency (CVI). The company discusses ongoing SAAVE pivotal trial with data expected in Q4 2022 and demonstrates sufficient capital to fund operations through the pivotal data readout.